Gary Gilliland - Articles and news items

Merck logo

Merck announces presentation of interim data from study evaluating Lambrolizumab

Industry news, News / 2 June 2013 / Merck

Merck expands Lambrolizumab clinical development program…

Merck logo
Merck logo

Merck presents early-stage interim data for MK-3475, an investigational therapy for the treatment of advanced Melanoma

Industry news, News / 11 November 2012 / Merck

Merck announced the presentation of early interim results…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+